CurrentAmeriHealth Caritas VIP CarePolicy CCP.1564

Home ultraviolet light therapy equipment for skin conditions

Customize your policy alerts

Sign up for amerihealth_caritas_vip_care Policy CCP.1564 alerts

Get alerted when Policy CCP.1564 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

This policy governs medical-necessity coverage for home ultraviolet phototherapy equipment used by members with selected photoresponsive skin conditions. It establishes covered home narrowband ultraviolet B criteria, required clinical documentation and safety controls, noncovered uses, and applicable equipment codes.

Policy Summary

PayerAmeriHealth Caritas VIP Care

PolicyHome ultraviolet light therapy equipment for skin conditions

Policy CodePolicy CCP.1564

Change TypeNo material change

Effective DateJuly 1, 2026

Last ReviewJun 1, 2026

Next Review DateOctober 1, 2027

Key ActionSubmit complete clinical and equipment documentation for prior authorization, including the qualifying diagnosis, home-treatment rationale, written treatment plan, safety features, training, and reassessment schedule.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

4Eligible photoresponsive condition categories

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentAmeriHealth Caritas VIP CarePolicy CCP.1564

Home ultraviolet light therapy equipment for skin conditions

Customize your policy alerts

Sign up for amerihealth_caritas_vip_care Policy CCP.1564 alerts

Get alerted when Policy CCP.1564 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerAmeriHealth Caritas VIP Care

PolicyHome ultraviolet light therapy equipment for skin conditions

Policy CodePolicy CCP.1564

Change TypeNo material change

Effective DateJuly 1, 2026

Last ReviewJun 1, 2026

Next Review DateOctober 1, 2027

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

4Eligible photoresponsive condition categories

Reassessment interval

311–313 nmNB-UVB therapeutic range

4HCPCS equipment codes

Not coveredHome UVA and PUVA

Coverage Criteria

Covered home narrowband ultraviolet B equipment

Home NB-UVB equipment may be medically necessary when ALL of the following criteria are met.

Covered home NB-UVB criteria

Qualified prescriber: The device is prescribed by a dermatologist or other qualified treating clinician experienced in ultraviolet phototherapy.
Qualifying photoresponsive condition
- Psoriasis with moderate-to-severe disease or clinically significant functional impairment.Moderate-to-severe disease or clinically significant functional impairment
- Vitiligo that is extensive, progressive, functionally significant, or localized and suitable for home treatment.Extensive, progressive, functionally significant, or localized and suitable for home treatment
- Atopic dermatitis that is moderate to severe and not adequately controlled with optimized topical therapy.Moderate to severe and inadequately controlled with optimized topical therapy
- Cutaneous lymphoma: Early-stage mycosis fungoides or Sezary syndrome for which NB-UVB is recommended as skin-directed therapy.Early-stage disease
Home setting is clinically necessary: Office- or facility-based ultraviolet B phototherapy is clinically appropriate but not reasonably feasible because of travel distance, limited local phototherapy availability, mobility or functional limitation, work or caregiving constraints, infection-risk or immunosuppression considerations, or another barrier that would materially impair adherence.
The treating clinician must document the barrier.
Written treatment plan: The treating clinician provides a written home phototherapy plan identifying the diagnosis, baseline severity or photographs, treatment area, device type and configuration, starting dose, dose escalation, treatment frequency, maximum exposure limits, missed-treatment instructions, adverse-event instructions, safety precautions, and follow-up schedule.
Appropriate equipment: The requested device size and configuration are appropriate for the affected body surface area and intended treatment sites.
Home safety features: The device includes a timer, dose or exposure controls, lockout or restricted-use capability, exposure tracking or treatment log, user instructions, and protective eyewear.
Safe operation: The member or caregiver has been trained and is able to operate the device safely and comply with the treatment plan.
Reassessment: The treating clinician reassesses the member after treatment initiation and at least every three to six months for clinical response, adherence, adverse effects, safe use, and continued need for home treatment.After initiation and at least every 3 to 6 months

Conventional therapy sequencing: For home ultraviolet equipment to be medically necessary, there must be an adequate trial of condition-appropriate conventional therapy unless it is contraindicated, not tolerated, or clinically inappropriate.

This limitation applies to all home ultraviolet equipment uses.

Home UVA and PUVA

The following home ultraviolet therapies are not medically necessary under this policy.

Investigational home ultraviolet therapies: Home ultraviolet A light therapy equipment and home psoralen ultraviolet A photochemotherapy equipment are investigational/not clinically proven for home use.

Other noncovered uses

All other uses of home ultraviolet light therapy equipment are not medically necessary.

Noncovered uses include tanning, wellness, cosmetic purposes, duplicate or upgraded equipment when an existing device is functional, use before an adequate trial of condition-appropriate conventional therapy unless contraindicated, not tolerated, or clinically inappropriate, use without a clinician's written treatment plan and scheduled follow-up, and use when contraindications make home ultraviolet exposure inappropriate.

Home UVA and home PUVA photochemotherapy equipment are investigational and not clinically proven for home use; therefore, they are not medically necessary under this policy.

Use of home ultraviolet light therapy equipment for tanning, wellness, or cosmetic purposes is excluded and is not medically necessary.

Duplicate or upgraded equipment is excluded when the member's existing device is functional.

Use of home ultraviolet equipment before an adequate trial of condition-appropriate conventional therapy is not medically necessary unless the conventional therapy is contraindicated, not tolerated, or clinically inappropriate.

Use without a clinician's written treatment plan and scheduled follow-up is not medically necessary.

Use is not medically necessary when contraindications make home ultraviolet exposure inappropriate.

Home UVA and home PUVA photochemotherapy equipment are not medically necessary because they are investigational and not clinically proven for home use.

Coding and Clinical Parameters

Related HCPCS CodesHCPCS

E0691	Ultraviolet light therapy system panel, includes bulbs/lamps, timer, and eye protection; treatment area 2 square feet or less.
E0692	Ultraviolet light therapy system panel, includes bulbs/lamps, timer, and eye protection; 4-foot panel.
E0693	Ultraviolet light therapy system panel, includes bulbs/lamps, timer, and eye protection; 6-foot panel.
E0694	Ultraviolet multidirectional light therapy system in 6-foot cabinet, includes bulbs/lamps, timer, and eye protection.

Clinical reassessment interval

Initial reassessmentAfter treatment initiation

Ongoing intervalAt least every 3 to 6 months

Reassessment includesClinical response, adherence, adverse effects, safe use, and continued need for home treatment

Common NB-UVB therapeutic wavelength

Therapeutic wavelengthApproximately 311 to 313 nm

Phototherapy typeNarrowband ultraviolet B

Purpose of range

Provider Documentation and Action Items

Prior Authorization

Complete Prior Authorization Documentation

Obtain prior authorization with complete clinical and equipment documentation. The request must identify a qualified prescriber experienced in ultraviolet phototherapy, establish medical necessity, and include the member’s treatment history and requested device details.

Prescriber: dermatologist or other qualified treating clinician experienced in ultraviolet phototherapy.
Document the qualifying diagnosis, disease severity or functional impact, prior conventional therapy, and why home treatment is needed.
Include device type, configuration, size, affected treatment sites, and home-use safety features.

Step Therapy

Conventional Therapy Must Be Tried First

Document an adequate trial of condition-appropriate conventional therapy before requesting home narrowband UVB, unless that therapy is contraindicated, not tolerated, or clinically inappropriate.

Describe the therapies tried, treatment response, and duration or adequacy of the trial.

Background

Home ultraviolet light therapy equipment is durable medical equipment that delivers controlled ultraviolet radiation outside a clinician's office or facility. Home treatment requires a prescription, dose controls, protective eyewear, user training, a written dosing plan, and periodic clinical reassessment because erythema and overexposure can occur.

Definitions

Narrowband ultraviolet B (NB-UVB)

DefinitionA form of ultraviolet B phototherapy that concentrates device output around a smaller therapeutic range

Common wavelengthNear 311 to 313 nm

Clinical purposeTo limit unnecessary ultraviolet exposure

Home ultraviolet light therapy equipment

DefinitionDurable medical equipment used to deliver controlled ultraviolet radiation outside a clinician office or facility

Equipment examplesHandheld lamps, localized panels, larger panels, and multidirectional cabinets

Required treatment features

Policy Summary

PayerAmeriHealth Caritas VIP Care

PolicyHome ultraviolet light therapy equipment for skin conditions

Policy CodePolicy CCP.1564

Change TypeNo material change

Effective DateJuly 1, 2026

Last ReviewJun 1, 2026

Next Review DateOctober 1, 2027

SourceLink

On This Page

To limit unnecessary ultraviolet exposure

Explain any contraindication, intolerance, or clinical reason conventional therapy cannot be used.

Documentation Required

Document Qualifying Diagnosis and Severity

Confirm and document a qualifying photoresponsive condition and the severity or functional impact supporting home treatment. Covered examples include moderate-to-severe or functionally impairing psoriasis, qualifying vitiligo, moderate-to-severe atopic dermatitis inadequately controlled with optimized topical therapy, and early-stage mycosis fungoides or Sezary syndrome when narrowband UVB is recommended.

Record the diagnosis and relevant clinical findings.
For vitiligo, document that disease is extensive, progressive, functionally significant, or localized and suitable for home treatment.
For atopic dermatitis, document moderate-to-severe disease and inadequate control with optimized topical therapy.

Documentation Required

Establish the Need for Home Treatment

Explain why clinically appropriate office- or facility-based UVB phototherapy is not reasonably feasible for the member. The treating clinician must document barriers that would materially impair adherence.

Examples include travel distance, limited local phototherapy availability, mobility or functional limitations, work or caregiving constraints, infection-risk or immunosuppression considerations, or other material access barriers.

Documentation Required

Provide a Written Home Phototherapy Plan

Submit a written home phototherapy plan from the treating clinician that supports safe, individualized treatment and follow-up.

Include diagnosis, baseline severity or photographs, treatment area, device type and configuration, starting dose, dose escalation, treatment frequency, and maximum exposure limits.
Specify missed-treatment instructions, adverse-event instructions, safety precautions, and the follow-up schedule.

Documentation Required

Document Training and Ongoing Monitoring

Document that the member or caregiver has been trained and can operate the device safely and follow the prescribed plan. Reassess after treatment initiation and at least every three to six months for response, adherence, adverse effects, safe use, and continued need.

Record member or caregiver training and ability to use the device safely.
Monitor adherence, treatment logs, clinical response, adverse effects, and ongoing appropriateness of home treatment.

Documentation Required

Verify Safety Controls and Photosensitivity Precautions

Confirm that the requested device has home-use safety controls and that the member has been screened and counseled regarding photosensitivity risks. The dosing plan and follow-up must address safe exposure, medication- or comorbidity-related photosensitivity, and skin cancer or photosensitive-disorder concerns.

Device should include a timer, dose or exposure controls, lockout or restricted-use capability, exposure tracking or treatment log, user instructions, and protective eyewear.
Screen for photosensitive disorders and skin cancer risk before treatment.
Adjust dosing and document precautions when medications or comorbid conditions increase photosensitivity; instruct the member to avoid unsafe exposure and report adverse effects.

Denial Risk

Avoid Noncovered and Unsafe Uses

Home UVA and home psoralen UVA photochemotherapy are investigational or not clinically proven for home use and are not medically necessary under this policy. Other noncovered or unsafe uses should be denied.

Not covered: home UVA or PUVA, tanning, wellness, or cosmetic use.
Not covered: treatment without a written clinician plan and scheduled follow-up, duplicate or upgraded equipment when the existing device is functional, or use when contraindications make home UV exposure inappropriate.

Denial Risk

Meet All Clinical and Equipment Criteria

Expect denial when the request does not establish a qualifying condition, required severity or functional impact, adequate conventional-therapy history, or a documented barrier to office- or facility-based treatment. Denial may also result when the written plan, follow-up, safety controls, training, or device size and configuration are missing or inappropriate.

The device must be appropriately sized and configured for the affected body surface area and intended treatment sites.
Requests lacking complete clinical documentation or failing the home-use equipment criteria do not meet medical-necessity requirements.

Clinician prescription, training, dose controls, protective eyewear, and periodic reassessment

Psoralen ultraviolet A (PUVA) photochemotherapy

DefinitionUltraviolet A treatment administered with psoralens

Home-use statusHome PUVA photochemotherapy equipment is investigational/not clinically proven for home use

Coverage statusNot medically necessary under this policy